Sign in to view content

Artificial Intelligence Screening for Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Exams

Jennifer I. Lim, MD, FARVO, FASRS

Video
Published 2020

Related

Evaluation of EZ At-Risk Burden in Automatic Detection of Hydroxychloroquine Retinopathy
Katherine E Talcott, MD
Annual Meeting Talks
2023
Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Andrew J. Barkmeier, MD
Updates from the Field
2024
Presumed Silicone Oil Droplets
Rahul N. Khurana, MD, FASRS
Updates from the Field
2017

Category: Diabetic Retinopathy

See more